KRYS logo

Krystal Biotech, Inc. (KRYS)

Profile

Full Name

Krystal Biotech, Inc.

Ticker

NASDAQ: KRYS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

September 20, 2017

Indexes

Not included

Website

https://www.krystalbio.com

Employees

275

Key Details

Price

$143.62(+4.42%)

Market cap

$4.16B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$290.51M(+473.02% YoY)

Annual EPS

$3.00(+669.23% YoY)

PE ratio

29.19

Next earnings date

Nov 3, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $143.62
    KRYS price is $143.62

    30-Day Relative Volume

    0.88
    KRYS 30-day relative volume is 0.88

    Price Performance

    Price Most recent change

    +4.42%
    KRYS price was up +4.42% on Aug 12, 2025

    Price YTD change

    -8.32%
    KRYS price is down -8.32% since January 1st

    Price 1-year change

    -23.39%
    KRYS price is down -23.39% year-on-year

    Price 3-year change

    +81.11%
    KRYS price is up +81.11% over the past 3 years

    Price Range

    Price All-time high

    $219.34
    KRYS price is currently -34.52% below its historical high of $219.34

    Price 3-year low

    $61.11
    KRYS price is currently +135.02% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $4.16B
    KRYS market capitalization is $4.16 billion

    Market cap 3-year change

    +114.98%
    KRYS market capitalization is up +114.98% over the past 3 years

    Market cap All-time high

    $6.13B
    KRYS market capitalization is currently -32.23% below its historical high of $6.13 billion

    Market cap sector rank

    87.74%
    KRYS market capitalization is higher than 87.74% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.74%
    KRYS shares outstanding is up +0.74% year-on-year

    Shares Outstanding 3-Year Change

    +12.78%
    KRYS shares outstanding is up +12.78% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.88
    KRYS beta is 0.88

    200-day SMA

    $160.52
    KRYS price is currently -10.53% below its 200-day simple moving average

    50-day SMA

    $142.06
    KRYS price is currently +1.10% above its 50-day simple moving average

    RSI

    49.50
    KRYS 14-day relative strength index is 49.50

    Volume

    0.88
    KRYS 30-day relative volume is 0.88

    ATR

    $6.16
    KRYS average true range is $6.16

    10-day Historical Volatility

    79.87%
    KRYS 10-day historical volatility is 79.87%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $290.51M
    KRYS annual revenue is $290.51 million

    Revenue Analysts estimate

    $383.74M
    KRYS annual revenue is currently -24.29% lower than the consensus analysts' forecast

    Revenue 1-year change

    +473.02%
    KRYS annual revenue is up +473.02% year-on-year

    Revenue Sector rank

    67.63%
    KRYS annual revenue is higher than 67.63% of companies in Healthcare sector

    EPS

    EPS

    $3.00
    KRYS annual earnings per share is $3.00

    EPS Analysts estimate

    $4.92
    KRYS annual earnings per share is currently -39.08% lower than the consensus analysts' forecast

    EPS 1-year change

    +669.23%
    KRYS annual earnings per share is up +669.23% year-on-year

    EPS Sector rank

    93.49%
    KRYS annual earnings per share is higher than 93.49% of companies in Healthcare sector

    Profit

    Gross profit

    $270.45M
    KRYS annual gross profit is $270.45 million

    Gross margin

    93.09%
    KRYS annual gross profit margin is 93.09%

    Operating profit

    $103.19M
    KRYS annual operating income is $103.19 million

    Operating margin

    35.52%
    KRYS annual operating profit margin is 35.52%

    Net income

    $89.16M
    KRYS annual net profit is $89.16 million

    Net margin

    30.69%
    KRYS annual net profit margin is 30.69%

    Expenses

    Total expenses

    $187.32M
    KRYS annual total expenses is $187.32 million

    Operating expenses

    $167.26M
    KRYS annual total operating expenses is $167.26 million

    Cost of goods sold

    $20.06M
    KRYS annual cost of goods sold is $20.06 million

    Selling, general & administrative expenses

    $113.69M
    KRYS annual SGA is $113.69 million

    Depreciation and amortization

    $6.71M
    KRYS annual depreciation & amortization is $6.71 million

    Interest expense

    -
    KRYS annual interest expense value is unknown

    Income tax

    $6.20M
    KRYS annual income tax is $6.20 million

    EBIT & EBITDA

    EBIT

    $103.19M
    KRYS annual earnings before interest & taxes is $103.19 million

    EBITDA

    $109.91M
    KRYS annual EBITDA is $109.91 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $1.06B
    KRYS annual total assets is $1.06 billion

    Non current assets

    $313.79M
    KRYS annual long term assets is $313.79 million

    Current assets

    $742.04M
    KRYS annual total current assets is $742.04 million

    Cash and cash equivalents

    $344.87M
    KRYS annual cash & cash equivalents is $344.87 million

    Accounts receivable

    $104.75M
    KRYS annual accounts receivable is $104.75 million

    Inventory

    $26.51M
    KRYS annual inventory is $26.51 million

    Liabilities

    Total liabilities

    $109.46M
    KRYS annual total liabilities is $109.46 million

    Long term liabilities

    $7.46M
    KRYS annual total long term liabilities is $7.46 million

    Current liabilities

    $102.00M
    KRYS annual total current liabilities is $102.00 million

    Accounts payable

    $4.99M
    KRYS annual accounts payable is $4.99 million

    Debt

    Total debt

    $7.26M
    KRYS annual total debt is $7.26 million

    Total debt 1-year change

    -10.29%
    KRYS annual total debt is down -10.29% year-on-year

    Long term debt

    $6.04M
    KRYS annual long term debt is $6.04 million

    Short term debt

    $1.22M
    KRYS annual short term debt is $1.22 million

    Equity & Capital

    Shareholders equity

    $946.38M
    KRYS annual stockholders equity is $946.38 million

    Book value

    $946.38M
    KRYS annual book value is $946.38 million

    Retained earnings

    -$180.67M
    KRYS annual retained earnings is -$180.67 million

    Working capital

    $640.05M
    KRYS annual working capital is $640.05 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $123.42M
    KRYS annual cash flow from operations is $123.42 million

    Cash from operations 1-year change

    +238.98%
    KRYS annual cash flow from operations is up +238.98% year-on-year

    Cash from investing

    -$163.44M
    KRYS annual cash flow from investing activities is -$163.44 million

    Cash from investing 1-year change

    -297.78%
    KRYS annual cash flow from investing activities is down -297.78% year-on-year

    Cash from financing

    $27.01M
    KRYS annual cash flow from financing activities is $27.01 million

    Cash from financing 1-year change

    -86.68%
    KRYS annual cash flow from financing activities is down -86.68% year-on-year

    CAPEX

    CAPEX

    $4.24M
    KRYS annual capital expenditures is $4.24 million

    CAPEX 1-year change

    -64.08%
    KRYS annual capital expenditures is down -64.08% year-on-year

    Free Cash Flow

    Free cash flow

    $119.18M
    KRYS annual free cash flow is $119.18 million

    Free cash flow 1-year change

    +218.47%
    KRYS annual free cash flow is up +218.47% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    93.09%
    KRYS annual gross profit margin is 93.09%

    Operating margin

    35.52%
    KRYS annual operating profit margin is 35.52%

    Net margin

    30.69%
    KRYS annual net profit margin is 30.69%

    ROA & ROE

    ROA

    9.51%
    KRYS annual return on assets is 9.51%

    ROE

    10.34%
    KRYS annual return on equity is 10.34%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    29.19
    KRYS price to earnings ratio is 29.19

    PE ratio Sector rank

    61.01%
    KRYS price to earnings ratio is higher than 61.01% of companies in Healthcare sector

    PB Ratio

    PB ratio

    3.99
    KRYS price to book ratio is 3.99

    PB ratio Sector rank

    74.58%
    KRYS price to book ratio is higher than 74.58% of companies in Healthcare sector

    PS Ratio

    PS ratio

    11.57
    KRYS price to sales ratio is 11.57

    PS ratio Sector rank

    79.32%
    KRYS price to sales ratio is higher than 79.32% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $3.81B
    KRYS enterprise value is $3.81 billion

    Enterprise value Sector rank

    85.83%
    KRYS enterprise value is higher than 85.83% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    24.12
    KRYS EV/EBITDA is 24.12

    EV/EBITDA Sector rank

    93.26%
    KRYS EV/EBITDA is higher than 93.26% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    7.28
    KRYS annual current ratio is 7.28

    Quick ratio

    7.02
    KRYS annual quick ratio is 7.02

    Leverage

    Debt to equity

    0.00
    KRYS annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    KRYS annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    7
    KRYS piotroski f-score is 7

    Altman Z-Score

    23.87
    KRYS altman z-score is 23.87

    Analyst ratings

    Recent major analysts updates

    Aug 5, 25 Citigroup
    Neutral
    Aug 5, 25 Chardan Capital
    Buy
    Jul 25, 25 HC Wainwright & Co.
    Buy
    Jul 25, 25 Chardan Capital
    Buy
    Jul 22, 25 B of A Securities
    Buy
    Jul 10, 25 Citigroup
    Neutral
    Jul 1, 25 Clear Street
    Buy
    Jun 24, 25 HC Wainwright & Co.
    Buy
    May 16, 25 Citigroup
    Neutral
    May 7, 25 Guggenheim
    Buy

    Institutional Ownership

    Screeners with KRYS included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    High Piotroski score stocks
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for Krystal Biotech, Inc.?
    • Does Krystal Biotech, Inc. pay dividends?
    • What sector is Krystal Biotech, Inc. in?
    • What industry is Krystal Biotech, Inc. in?
    • What country is Krystal Biotech, Inc. based in?
    • When did Krystal Biotech, Inc. go public?
    • Is Krystal Biotech, Inc. in the S&P 500?
    • Is Krystal Biotech, Inc. in the NASDAQ 100?
    • Is Krystal Biotech, Inc. in the Dow Jones?
    • When was Krystal Biotech, Inc.'s last earnings report?
    • When does Krystal Biotech, Inc. report earnings?

    What is the ticker symbol for Krystal Biotech, Inc.?

    The ticker symbol for Krystal Biotech, Inc. is NASDAQ:KRYS

    Does Krystal Biotech, Inc. pay dividends?

    No, Krystal Biotech, Inc. does not pay dividends

    What sector is Krystal Biotech, Inc. in?

    Krystal Biotech, Inc. is in the Healthcare sector

    What industry is Krystal Biotech, Inc. in?

    Krystal Biotech, Inc. is in the Biotechnology industry

    What country is Krystal Biotech, Inc. based in?

    Krystal Biotech, Inc. is headquartered in United States

    When did Krystal Biotech, Inc. go public?

    Krystal Biotech, Inc.'s initial public offering (IPO) was on September 20, 2017

    Is Krystal Biotech, Inc. in the S&P 500?

    No, Krystal Biotech, Inc. is not included in the S&P 500 index

    Is Krystal Biotech, Inc. in the NASDAQ 100?

    No, Krystal Biotech, Inc. is not included in the NASDAQ 100 index

    Is Krystal Biotech, Inc. in the Dow Jones?

    No, Krystal Biotech, Inc. is not included in the Dow Jones index

    When was Krystal Biotech, Inc.'s last earnings report?

    Krystal Biotech, Inc.'s most recent earnings report was on August 4, 2025

    When does Krystal Biotech, Inc. report earnings?

    The next expected earnings date for Krystal Biotech, Inc. is November 3, 2025
    On this page